PROFICIENCY OF NERVE CONDUCTION USING STANDARD METHODS AND REFERENCE VALUES (Cl. NPhys TRIAL 4)

被引:25
作者
Litchy, William J. [1 ]
Albers, James W. [2 ]
Wolfe, James [2 ]
Bolton, Charles F. [3 ]
Walsh, Nancy [3 ]
Klein, Christopher J. [1 ]
Zafft, Andrew J. [1 ]
Russell, James W. [4 ]
Zwirlein, Melanie [4 ]
Overland, Carol J. [1 ]
Davies, Jenny L. [1 ]
Carter, Rickey E. [5 ]
Dyck, Peter J. [1 ]
机构
[1] Mayo Clin, Dept Neurol, Rochester, MN 55905 USA
[2] Univ Michigan, Dept Neurol, Ann Arbor, MI USA
[3] Queens Univ, Dept Neurol, Kingston, ON, Canada
[4] Univ Maryland, Dept Neurol, Baltimore, MD 21201 USA
[5] Mayo Clin, Div Biomed Stat & Informat, Rochester, MN 55905 USA
关键词
multicenter trial; nerve conduction accuracy; nerve conduction proficiency; neuropathy impairment score; reference values; ALPHA-LIPOIC ACID; DIABETIC POLYNEUROPATHY; GROWTH-FACTOR; NEUROPATHY; EFFICACY; SAFETY;
D O I
10.1002/mus.24243
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
IntroductionThe Cl. NPhys Trial 3 showed that attributes of nerve conduction (NC) were without significant intraobserver differences, although there were significant interobserver differences. Methods: Trial 4 tested whether use of written instructions and pretrial agreement on techniques and use of standard reference values, diagnostic percentile values, or broader categorization of abnormality could reduce significant interobserver disagreement and improve agreement among clinical neurophysiologists. Results: The Trial 4 modifications markedly decreased, but did not eliminate, significant interobserver differences of measured attributes of NC. Use of standard reference values and defined percentile values of abnormality decreased interobserver disagreement and improved agreement of judgment of abnormality among evaluators. Therefore, the same clinical neurophysiologist should perform repeat NCs of therapeutic trial patients. Conclusions: Differences in interobserver judgment of abnormality decrease with use of common standard reference values and a defined percentile level of abnormality, providing a rationale for their use in therapeutic trials and medical practice. Muscle Nerve 50: 900-908, 2014
引用
收藏
页码:900 / 908
页数:9
相关论文
共 17 条
  • [1] Efficacy and safety of recombinant human nerve growth factor in patients with diabetic polyneuropathy - A randomized controled trial
    Apfel, SC
    Schwartz, S
    Adornato, BT
    Freeman, R
    Biton, V
    Rendell, M
    Vinik, A
    Giuliani, M
    Stevens, JC
    Barbano, R
    Dyck, PJ
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2000, 284 (17): : 2215 - 2221
  • [2] Repurposing Diflunisal for Familial Amyloid Polyneuropathy A Randomized Clinical Trial
    Berk, John L.
    Suhr, Ole B.
    Obici, Laura
    Sekijima, Yoshiki
    Zeldenrust, Steven R.
    Yamashita, Taro
    Heneghan, Michael A.
    Gorevic, Peter D.
    Litchy, William J.
    Wiesman, Janice F.
    Nordh, Erik
    Corato, Manuel
    Lozza, Alessandro
    Cortese, Andrea
    Robinson-Papp, Jessica
    Colton, Theodore
    Rybin, Denis V.
    Bisbee, Alice B.
    Ando, Yukio
    Ikeda, Shu-ichi
    Seldin, David C.
    Merlini, Giampaolo
    Skinner, Martha
    Kelly, Jeffery W.
    Dyck, Peter J.
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2013, 310 (24): : 2658 - 2667
  • [3] INTER-EXAMINER AND INTRA-EXAMINER RELIABILITY OF NERVE-CONDUCTION MEASUREMENTS IN NORMAL SUBJECTS
    CHAUDHRY, V
    CORNBLATH, DR
    MELLITS, ED
    AVILA, O
    FREIMER, ML
    GLASS, JD
    REIM, J
    RONNETT, GV
    QUASKEY, SA
    KUNCL, RW
    [J]. ANNALS OF NEUROLOGY, 1991, 30 (06) : 841 - 843
  • [4] MULTICENTER TRIAL OF THE PROFICIENCY OF SMART QUANTITATIVE SENSATION TESTS
    Dyck, Peter J.
    Argyros, Barbara
    Russell, James W.
    Gahnstrom, Linde E.
    Nalepa, Susan
    Albers, James W.
    Lodermeier, Karen A.
    Zafft, Andrew J.
    Dyck, P. James B.
    Klein, Christopher J.
    Litchy, William J.
    Davies, Jenny L.
    Carter, Rickey E.
    Melton, L. Joseph, III
    [J]. MUSCLE & NERVE, 2014, 49 (05) : 645 - 653
  • [5] A TRIAL OF PROFICIENCY OF NERVE CONDUCTION: GREATER STANDARDIZATION STILL NEEDED
    Dyck, Peter J.
    Albers, James W.
    Wolfe, James
    Bolton, Charles F.
    Walsh, Nancy
    Klein, Christopher J.
    Zafft, Andrew J.
    Russell, James W.
    Thomas, Karen
    Davies, Jenny L.
    Carter, Rickey E.
    Melton, L. Joseph, III
    Litchy, William J.
    [J]. MUSCLE & NERVE, 2013, 48 (03) : 369 - 374
  • [6] "Unequivocally Abnormal" vs "Usual" Signs and Symptoms for Proficient Diagnosis of Diabetic Polyneuropathy Cl vs N Phys Trial
    Dyck, Peter J.
    Overland, Carol J.
    Low, Phillip A.
    Litchy, William J.
    Davies, Jenny L.
    Dyck, P. James B.
    Carter, Rickey E.
    Melton, L. Joseph, III
    Andersen, Henning
    Albers, James W.
    Bolton, Charles F.
    England, John D.
    Klein, Christopher J.
    Llewelyn, Gareth
    Mauermann, Michelle L.
    Russell, James W.
    Selvarajah, Dinesh
    Singer, Wolfgang
    Smith, Gordon
    Tesfaye, Solomon
    Vella, Adrian
    [J]. ARCHIVES OF NEUROLOGY, 2012, 69 (12) : 1609 - 1614
  • [7] SIGNS AND SYMPTOMS VERSUS NERVE CONDUCTION STUDIES TO DIAGNOSE DIABETIC SENSORIMOTOR POLYNEUROPATHY: Cl VS. NPhys TRIAL
    Dyck, Peter J.
    Overland, Carol J.
    Low, Phillip A.
    Litchy, William J.
    Davies, Jenny L.
    Dyck, P. James B.
    O'Brien, Peter C.
    [J]. MUSCLE & NERVE, 2010, 42 (02) : 157 - 164
  • [8] PREDNISONE IMPROVES CHRONIC INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY MORE THAN NO TREATMENT
    DYCK, PJ
    OBRIEN, PC
    OVIATT, KF
    DINAPOLI, RP
    DAUBE, JR
    BARTLESON, JD
    MOKRI, B
    SWIFT, T
    LOW, PA
    WINDEBANK, AJ
    [J]. ANNALS OF NEUROLOGY, 1982, 11 (02) : 136 - 141
  • [9] VARIABLES INFLUENCING NEUROPATHIC END-POINTS - THE ROCHESTER DIABETIC NEUROPATHY STUDY OF HEALTHY-SUBJECTS
    DYCK, PJ
    LITCHY, WJ
    LEHMAN, KA
    HOKANSON, JL
    LOW, PA
    OBRIEN, PC
    [J]. NEUROLOGY, 1995, 45 (06) : 1115 - 1121
  • [10] Grant IA, 2005, PERIPHERAL NEUROPATH, V1, P1163